ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP11

Living Well with Chronic Illness: Decades with MCTD

Carol KAMINSKI, HP (Hewlett Packard) Retired, Wilmington, NC

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, lupus-like disease, Miscellaneous Rheumatic and Inflammatory Diseases, Raynaud's, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Patient Perspectives Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30AM

Background/Purpose: In the fall of 1985, I was not feeling well. I attributed my tiredness, weakness and malaise to stress and carried on. Walking upstairs I was out of breath and muscle sore.  I went to my aerobics class and could not keep up.  I tried all manner of stress reduction that had worked in the past for me.  Reading, walking, talking to friends, naps.  Many naps. Then I woke up one morning and fingers on both hands were very swollen. They hurt and I couldn’t close them. As a 26-year-old, doctor visits were infrequent, but I called a local Internist and made an appointment.  After my bloodwork was relatively normal, he declared I was fine. I asked for a referral.  He referred me to Cardiology.  After a cardiac workup, the doctor declared I “did not have a disease in his specialty.”  He referred me to a Rheumatologist.  In a few short months I was diagnosed with Mixed Connective Tissue Disease (MCTD).  The rashes, fevers, joint and muscle pain, and later swallowing and GI problems made sense.  My extreme fatigue and associated issues had a name.  Medical therapy started and over the next years, I became used to adjusting to various therapies.

Intervention: A diagnosis with chronic illness taught me to learn new skills.  These included enhancing my ability to listen to and share with medical staff so I could receive the best care. This applied to communication with friends and family.  Making modifications so I could still do the things I enjoyed.  At the time I loved racquet sports.  But when I would play the skin on my fingers would split from the stress over my skin and joints.  By using leather gloves when playing any sports I found it protected my hands and made my time enjoyable instead of my being preoccupied with hurting myself.  Although a small change, this was pivotal to me because it encouraged me to make changes anytime I encountered an obstacle.  When the Lupus part of my disease was most active, I requested a work accommodation away from windows and sunlight.  Working in training technology when the disease was more active, I would request non-stop flights when traveling for work to reduce joint and fatigue issues.  The swallowing issues that arose when the Scleroderma part of the disease became more evident were harder to accommodate.  My doctor prescribed medications that represented the latest approaches to handling motility and swallowing issues.  But the most important thing he did was empathize with how difficult this issue is to manage.  He expressed confidence that I was able to handle this challenge and noted how well I was faring overall.  More than anything, living with a chronic illness has required me to adapt and change according to my circumstances.

Maintenance: I can actually thank the entrance of illness in my life in my 20’s for teaching me life lessons about developing personal resilience and teaching me to depend upon others when necessary.

Quality of Life: After nearly 40 years living with MCTD, I can say I am living well with chronic illness. My disease has been in remission for the last 15 years.  GI (mainly swallowing) issues have never abated but I manage them via medication and lifestyle modifications.  I retired early from a 30-year career that I enjoyed, and look forward to aging well, something my 26-year-old self could not have imagined.


Disclosures: C. KAMINSKI: None.

To cite this abstract in AMA style:

KAMINSKI C. Living Well with Chronic Illness: Decades with MCTD [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/living-well-with-chronic-illness-decades-with-mctd/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/living-well-with-chronic-illness-decades-with-mctd/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology